Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM
Published: March 10th 2025 | Updated: March 21st 2025If approved, vutrisiran would be the first FDA-approved therapy to treat both the polyneuropathy and cardiomyopathy aspects of transthyretin amyloidosis (ATTR).
Read More